Merger and Acquisition Activity Expected to Rise in 2013 as Big Pharma Companies Flush With Cash

Five Star Equities Provides Stock Research on Biosante Pharmaceuticals and Cell Therapeutics

Continue Reading

Record Levels of Available Cash and Moderate R&D Development Will See Big Pharma M&A Activity Increase in 2013

Five Star Equities Provides Stock Research on Achillion Pharmaceuticals and Dendreon

Continue Reading

Baltic Dry Index Posts First Increase Since November as Iron Ore Shipments on the Rise

Five Star Equities Provides Stock Research on Navios Maritime Holdings and Paragon Shipping

Continue Reading

Improving Chinese Steel Demand Sends Iron Ore Prices Soaring to 15-Month Highs

The Paragon Report Provides Stock Research on Champion Iron Mines and Labrador Iron Mines

Continue Reading

Improving Chinese Steel Demand Sends Iron Ore Prices Soaring to 15-Month Highs

The Paragon Report Provides Stock Research on Cliffs Natural Resources and Rio Tinto

Continue Reading

Higher Rate of FDA New Drug Approvals a Major Factor in Biotech Industry-s Success in 2012

Five Star Equities Provides Stock Research on Inovio Pharmaceuticals and Rexahn Pharmaceuticals

Continue Reading

DryShips and Eagle Bulk Shipping Shares Soar as Baltic Dry Index Rises for the First Time Since November

Five Star Equities Provides Stock Research on DryShips and Eagle Bulk Shipping

Continue Reading

Uranium Industry on the Upswing as Uranium Demand From Japan Speculated to Rise

The Paragon Report Provides Stock Research on Uranium Resources and USEC

Continue Reading

Baltic Dry Index Posts First Increase Since November as Iron Ore Shipments on the Rise

Five Star Equities Provides Stock Research on Genco Shipping & Trading and Excel Maritime Carriers

Continue Reading

Chinese Iron Exports Expected to Rise as Inventories Are Near Two-Year Lows

The Paragon Report Provides Stock Research on ArcelorMittal and Vale

Continue Reading